Sagent Pharmaceuticals Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Sagent Pharmaceuticals Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C11397
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sagent Pharmaceuticals Inc (Sagent), formerly Sagent Holding Co, a subsidiary of Nichi-Iko Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and manufactures injectable products. The company offers products such as amikacin sulfate injection, USP, ampicillin and sulbactam for injection, ampicillin for injection, USP, azithromycin for injection, cefazolin for injection, USP, cefepime for injection, acetazolamide for injection, and adenosine injection. It also offers busulfan injection and pentobarbital sodium injection, USP. The company provides its products in injection and oral dosage forms. It markets its products across the US. Sagent is headquartered in Schaumburg, Illinois, the US.

Sagent Pharmaceuticals Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sagent Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Sagent Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sagent Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Sagent Pharma Completes Public Offering Of Shares For US$75.3 Million 10
Acquisition 12
Nichi-iko Pharma Acquires Sagent Pharma for USD734.2 Million in Tender Offer 12
Sagent Pharma Acquires Omega Labs for USD85.3 Million 14
Sagent Pharmaceuticals Inc – Key Competitors 15
Sagent Pharmaceuticals Inc – Key Employees 16
Sagent Pharmaceuticals Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Sagent Pharmaceuticals Inc, Medical Equipment, Key Facts 2
Sagent Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sagent Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sagent Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8
Sagent Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sagent Pharma Completes Public Offering Of Shares For US$75.3 Million 10
Nichi-iko Pharma Acquires Sagent Pharma for USD734.2 Million in Tender Offer 12
Sagent Pharma Acquires Omega Labs for USD85.3 Million 14
Sagent Pharmaceuticals Inc, Key Competitors 15
Sagent Pharmaceuticals Inc, Key Employees 16
Sagent Pharmaceuticals Inc, Subsidiaries 17
Sagent Pharmaceuticals Inc, Joint Venture 17

List of Figures
Sagent Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sagent Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Sagent Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sagent Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Sagent Pharmaceuticals Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BKW AG (BKW):電力:M&Aディール及び事業提携情報
    Summary BKW AG (BKW) is an energy and infrastructure company, which plans, builds and operates infrastructure to produce and supply energy. It generates electricity from varied fuel sources such as hydro, nuclear, fossil, and renewable sources primarily, wind and small hydro, besides solar and bioma …
  • Electricity Supply Board:企業の戦略・SWOT・財務分析
    Electricity Supply Board - Strategy, SWOT and Corporate Finance Report Summary Electricity Supply Board - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Exillon Energy Plc (EXI):企業の財務・戦略的SWOT分析
    Summary Exillon Energy Plc (Exillon) is an oil exploration and production company. The company explores, produces and develops crude oil. Its services include drilling, exploration, appraisal, development, operations, management, and production services. Exillon’s operating assets are located in two …
  • Sharp Corporation:企業の戦略・SWOT・財務分析
    Sharp Corporation - Strategy, SWOT and Corporate Finance Report Summary Sharp Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • PharmaEssentia Corp (6446)-製薬・医療分野:企業M&A・提携分析
    Summary PharmaEssentia Corp (PharmaEssentia) is a research and development company that develops therapeutic products for the treatment of human diseases. The company’s pipeline product include P1101, a new generation PEG-Interferon-alpha-2b which is developed using PEGylation technology platform. I …
  • Recipharm AB (RECI B):企業の財務・戦略的SWOT分析
    Recipharm AB (RECI B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bayer AG:企業の戦略・SWOT・財務情報
    Bayer AG - Strategy, SWOT and Corporate Finance Report Summary Bayer AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • A. O. Smith Corporation:企業の戦略・SWOT・財務情報
    A. O. Smith Corporation - Strategy, SWOT and Corporate Finance Report Summary A. O. Smith Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • MetaStat Inc (MTST):医療機器:M&Aディール及び事業提携情報
    Summary MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable …
  • Marubeni Power International Inc:電力:M&Aディール及び事業提携情報
    Summary Marubeni Power International Inc (Marubeni Power International), formerly National Power Development Inc, a subsidiary of Marubeni Corp, is an energy service provider that offers electricity generation and transmission services. The company acquires established power generation portfolios an …
  • Isagen SA ESP:発電所・企業SWOT分析
    Isagen SA ESP - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • Univalor Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Univalor Inc (Univalor) is a university technology transfer organization that optimizes research outcomes by commercializing the technological innovations of researchers from health centers and academic institutions. The organization provides researcher services such as protecting intellectu …
  • Allergy Therapeutics Plc (AGY):企業の財務・戦略的SWOT分析
    Allergy Therapeutics Plc (AGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Hafslund ASA:企業の戦略的SWOT分析
    Hafslund ASA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Korea Research Institute of Bioscience and Biotechnology:製薬・医療:M&Aディール及び事業提携情報
    Summary Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute which provides bioinformatic services. The institute operates in the fields of strategic research, biomedical sciences, system biology and bioengineering, business development, and bioinfrastr …
  • Farbest-Tallman Foods Corp.:企業の戦略・SWOT・財務分析
    Farbest-Tallman Foods Corp. - Strategy, SWOT and Corporate Finance Report Summary Farbest-Tallman Foods Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Intelligent InSites Inc-医療機器分野:企業M&A・提携分析
    Summary Intelligent InSites Inc (Insites) is a healthcare technology company that provides technology services and automation solutions for health care organizations. The company offers implantation, training, technical support, product maintenance and solution services. Its solution include additio …
  • s.a. D’leteren n.v.:企業の戦略・SWOT・財務情報
    s.a. D'leteren n.v. - Strategy, SWOT and Corporate Finance Report Summary s.a. D'leteren n.v. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CommVault Systems Inc (CVLT):企業の財務・戦略的SWOT分析
    CommVault Systems Inc (CVLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Panda Green Energy Group Ltd:企業のM&A・事業提携・投資動向
    Panda Green Energy Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Panda Green Energy Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆